AZN
14039.56 GBP
+1.58%
Today
+1.64%
1D
Market is open
Sun
Closed
Mon
10:01 AM ~ 6:30 PM
Tue
10:01 AM ~ 6:30 PM
Wed
10:01 AM ~ 6:30 PM
Thu
10:01 AM ~ 6:30 PM
Fri
10:01 AM ~ 6:30 PM
Sat
Closed
Information
Name
AstraZeneca Leveraged ( UK )
Currency
GBP
Core Leverage
1:2
Plus Leverage
1:2
Max Leverage
1:2
Overnight Fees Buy (Core Leverage)
-0.0187%
Overnight Fees Sell (Core Leverage)
0.0020%
Overnight Fees Buy (Plus Leverage)
-0.0187%
Overnight Fees Sell (Plus Leverage)
0.0020%
Overnight Fees Buy (Max Leverage)
-0.0187%
Overnight Fees Sell (Max Leverage)
0.0020%
Market Cap
213.41B
Avg Daily Volume
3.12M
52 Week High
15732 GBP
52 Week Low
9892 GBP
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01870% | $(0.187) |
| SELLS | 0.00200% | $0.020 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies for rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, USA, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of oral candidates; Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates; and Carterra, Inc. to advances lab-in-the-loop drug discovery through new scientific research collaboration. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is based in Cambridge, the United Kingdom.
Top News
AstraZeneca (LSE:AZN) Filing Acceptance In Europe And Japan Puts Lung Cancer Combo Forward
finance.yahoo.com
1h ago
AmgenInc
+4.42%
RoperTechn
+13.26%
Merck(US)
+2.54%
RNA Targeting Small Molecule Drug Discovery Market - Global Strategic Business Report: Secure a US$5.3B Market by 2030 as Amgen, AstraZeneca, Roche and Merck Accelerate RNA Pipelines
finance.yahoo.com
2d ago
OncoC4 Appoints Dr. Dan Janiak as Chief Business Officer
finance.yahoo.com
2d ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
